New Zealand | Imports and Exports | World | Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 051000 "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" from New Zealand totalled $ 18.3 million in 2023. Sales of commodity group 051000 from New Zealand went up by 3.76% compared to 2022: exports of commodity group 051000 "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" went up by $ 664 thousand (cumulative exports of commodity group 051000 from New Zealand amounted $17.6 million in 2022)
Exports of commodity group 051000 "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" amounted to 0.043% of total exports from New Zealand (cumulative merchandise exports from New Zealand totalled $ 42 billion in 2023). The share of commodity group 051000 in total exports from New Zealand increased by 0.004 p.p. compared to 2022 (it was 0.038% in 2022 and cumulative exports from New Zealand were equal to $ 45 billion).
Exports of commodity group 051000 amounted to 4.13% of total sales of group "" from New Zealand in 2023 (the value of exports of commodity group from New Zealand amounted to $443 million in 2023). The share of exports of commodity group 051000 in sales of commodity group from New Zealand increased by 0.416 p.p. compared to 2022 (it was 3.71% in 2022, and exports of commodity group from New Zealand were $474 million).
Where does New Zealand export Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products?
Top export destinations of "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" from New Zealand in 2023:
- Japan with a share of 51% (9.42 million US$)
- USA with a share of 15.4% (2.83 million US$)
- India with a share of 11.1% (2.04 million US$)
- Italy with a share of 6.1% (1.11 million US$)
- United Kingdom with a share of 3.91% (717 thousand US$)
- Germany with a share of 3.66% (671 thousand US$)
- China with a share of 2.77% (507 thousand US$)
- Hong Kong with a share of 2.25% (412 thousand US$)
- Korea - 126 thousand US$
- France - 120 thousand US$
The value of imports of commodity group 051000 "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" to New Zealand totalled $ 17.4 million in 2023. Sales of commodity group 051000 to New Zealand went up by 161% compared to 2022: imports of commodity group 051000 "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" went up by $ 10.7 million (the value of imports of commodity group 051000 to New Zealand was equal to $6.67 million in 2022)
Imports of commodity group 051000 "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products" accounted for 0.034% of total import flow to New Zealand (in 2023, total imports to New Zealand amounted to $ 50 billion). The share of commodity group 051000 in total imports to New Zealand increased by 0.022 p.p. compared to 2022 (it was 0.012% in 2022 and cumulative imports to New Zealand were equal to $ 54 billion).
Imports of commodity group 051000 reached 43% of total imports of group "" to New Zealand in 2023 (imports of commodity group to New Zealand totalled $40 million in 2023). The share of purchases of commodity group 051000 in total imports of commodity group to New Zealand increased by 21 p.p. compared to 2022 (it was 22% in 2022, and imports of commodity group to New Zealand accounted for $30 million).
Where does New Zealand import Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products from?
Top trading partners (import of "Ambergris, castoreum, civet & musk; cantharides; bile; glands & other animal products used in the preparation of pharmaceutical products") of New Zealand in 2023:
- USA with a share of 25% (4.4 million US$)
- Italy with a share of 18.1% (3.17 million US$)
- India with a share of 16.7% (2.92 million US$)
- Colombia with a share of 14% (2.44 million US$)
- Mexico with a share of 7.76% (1.35 million US$)
- Canada with a share of 4.26% (743 thousand US$)
- Australia with a share of 4.25% (742 thousand US$)
- Brazil with a share of 4.07% (710 thousand US$)
- Kenya with a share of 2.69% (469 thousand US$)
- Argentina - 167 thousand US$
